These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 26135883)

  • 1. Fluorescence-guided surgery of human prostate cancer experimental bone metastasis in nude mice using anti-CEA DyLight 650 for tumor illumination.
    Miwa S; De Magalhães N; Toneri M; Zhang Y; Cao W; Bouvet M; Tsuchiya H; Hoffman RM
    J Orthop Res; 2016 Apr; 34(4):559-65. PubMed ID: 26135883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescence-guided surgery of prostate cancer bone metastasis.
    Miwa S; Matsumoto Y; Hiroshima Y; Yano S; Uehara F; Yamamoto M; Zhang Y; Kimura H; Hayashi K; Yamamoto N; Bouvet M; Sugimoto N; Tsuchiya H; Hoffman RM
    J Surg Res; 2014 Nov; 192(1):124-33. PubMed ID: 24972740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved disease-free survival and overall survival after fluorescence-guided surgery of liver metastasis in an orthotopic nude mouse model.
    Murakami T; Hiroshima Y; Zhang Y; Bouvet M; Chishima T; Tanaka K; Endo I; Hoffman RM
    J Surg Oncol; 2015 Aug; 112(2):119-24. PubMed ID: 26266663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective fluorescence-guided surgery of liver metastasis using a fluorescent anti-CEA antibody.
    Hiroshima Y; Lwin TM; Murakami T; Mawy AA; Kuniya T; Chishima T; Endo I; Clary BM; Hoffman RM; Bouvet M
    J Surg Oncol; 2016 Dec; 114(8):951-958. PubMed ID: 27696448
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eradication of osteosarcoma by fluorescence-guided surgery with tumor labeling by a killer-reporter adenovirus.
    Yano S; Miwa S; Kishimoto H; Urata Y; Tazawa H; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    J Orthop Res; 2016 May; 34(5):836-44. PubMed ID: 26479501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorescence-guided surgery of retroperitoneal-implanted human fibrosarcoma in nude mice delays or eliminates tumor recurrence and increases survival compared to bright-light surgery.
    Uehara F; Hiroshima Y; Miwa S; Tome Y; Yano S; Yamamoto M; Matsumoto Y; Maehara H; Tanaka K; Bouvet M; Kanaya F; Hoffman RM
    PLoS One; 2015; 10(2):e0116865. PubMed ID: 25710463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence-guided surgery, but not bright-light surgery, prevents local recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) model resistant to neoadjuvant chemotherapy (NAC).
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    Pancreatology; 2015; 15(3):295-301. PubMed ID: 25800176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Photoimmunotherapy lowers recurrence after pancreatic cancer surgery in orthotopic nude mouse models.
    Maawy AA; Hiroshima Y; Zhang Y; Garcia-Guzman M; Luiken GA; Kobayashi H; Hoffman RM; Bouvet M
    J Surg Res; 2015 Jul; 197(1):5-11. PubMed ID: 25799527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence-guided surgery in combination with UVC irradiation cures metastatic human pancreatic cancer in orthotopic mouse models.
    Hiroshima Y; Maawy A; Zhang Y; Sato S; Murakami T; Yamamoto M; Uehara F; Miwa S; Yano S; Momiyama M; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2014; 9(6):e99977. PubMed ID: 24924955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence-guided surgery improves outcome in an orthotopic osteosarcoma nude-mouse model.
    Miwa S; Hiroshima Y; Yano S; Zhang Y; Matsumoto Y; Uehara F; Yamamoto M; Kimura H; Hayashi K; Bouvet M; Tsuchiya H; Hoffman RM
    J Orthop Res; 2014 Dec; 32(12):1596-601. PubMed ID: 25138581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenoviral targeting of malignant melanoma for fluorescence-guided surgery prevents recurrence in orthotopic nude-mouse models.
    Yano S; Takehara K; Kishimoto H; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2016 Apr; 7(14):18558-72. PubMed ID: 26701857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metastatic recurrence in a pancreatic cancer patient derived orthotopic xenograft (PDOX) nude mouse model is inhibited by neoadjuvant chemotherapy in combination with fluorescence-guided surgery with an anti-CA 19-9-conjugated fluorophore.
    Hiroshima Y; Maawy A; Zhang Y; Murakami T; Momiyama M; Mori R; Matsuyama R; Katz MH; Fleming JB; Chishima T; Tanaka K; Ichikawa Y; Endo I; Hoffman RM; Bouvet M
    PLoS One; 2014; 9(12):e114310. PubMed ID: 25463150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluorescence-Guided Surgery of Liver Metastasis in Orthotopic Nude-Mouse Models.
    Murakami T; Hiroshima Y; Zhang Y; Chishima T; Tanaka K; Bouvet M; Endo I; Hoffman RM
    PLoS One; 2015; 10(10):e0138752. PubMed ID: 26427050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting tumors with a killer-reporter adenovirus for curative fluorescence-guided surgery of soft-tissue sarcoma.
    Yano S; Miwa S; Kishimoto H; Uehara F; Tazawa H; Toneri M; Hiroshima Y; Yamamoto M; Urata Y; Kagawa S; Bouvet M; Fujiwara T; Hoffman RM
    Oncotarget; 2015 May; 6(15):13133-48. PubMed ID: 26033451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bisphosphonate olpadronate inhibits skeletal prostate cancer progression in a green fluorescent protein nude mouse model.
    Yang M; Burton DW; Geller J; Hillegonds DJ; Hastings RH; Deftos LJ; Hoffman RM
    Clin Cancer Res; 2006 Apr; 12(8):2602-6. PubMed ID: 16638872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental Curative Fluorescence-guided Surgery of Highly Invasive Glioblastoma Multiforme Selectively Labeled With a Killer-reporter Adenovirus.
    Yano S; Miwa S; Kishimoto H; Toneri M; Hiroshima Y; Yamamoto M; Bouvet M; Urata Y; Tazawa H; Kagawa S; Fujiwara T; Hoffman RM
    Mol Ther; 2015 Jul; 23(7):1182-1188. PubMed ID: 25896244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescence-guided surgery with a fluorophore-conjugated antibody to carcinoembryonic antigen (CEA), that highlights the tumor, improves surgical resection and increases survival in orthotopic mouse models of human pancreatic cancer.
    Metildi CA; Kaushal S; Pu M; Messer KA; Luiken GA; Moossa AR; Hoffman RM; Bouvet M
    Ann Surg Oncol; 2014 Apr; 21(4):1405-11. PubMed ID: 24499827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advantages of fluorescence-guided laparoscopic surgery of pancreatic cancer labeled with fluorescent anti-carcinoembryonic antigen antibodies in an orthotopic mouse model.
    Metildi CA; Kaushal S; Luiken GA; Hoffman RM; Bouvet M
    J Am Coll Surg; 2014 Jul; 219(1):132-41. PubMed ID: 24768506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence-guided surgery of human colon cancer increases complete resection resulting in cures in an orthotopic nude mouse model.
    Metildi CA; Kaushal S; Snyder CS; Hoffman RM; Bouvet M
    J Surg Res; 2013 Jan; 179(1):87-93. PubMed ID: 23079571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ratiometric activatable cell-penetrating peptides label pancreatic cancer, enabling fluorescence-guided surgery, which reduces metastases and recurrence in orthotopic mouse models.
    Metildi CA; Felsen CN; Savariar EN; Nguyen QT; Kaushal S; Hoffman RM; Tsien RY; Bouvet M
    Ann Surg Oncol; 2015; 22(6):2082-7. PubMed ID: 25319581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.